Latham & Watkins represented Santa Clara, California-based graphics chipmaker NVIDIA in its acquisition of chipmaker Arm from SoftBank, which worked with Morrison & Foerster, for $40 billion, and Davis Polk & Wardwell represented biopharmaceutical company Gilead Sciences in its $21 billion acquisition of cancer treatment leader Immunomedics, which worked with Wachtell, Lipton, Rosen & Katz on a Sunday that included two of the top 10 deals of the year by value.The Latham team was led by an international team of M&A partners including Josh Dubofsky (Silicon Valley), Charles Ruck (New York), Ed Barnett and Farah O’Brien (London), Joshua Holian (San Francisco), Sven Volcker (Brussels) and Les Carnegie (Washington, D.C.). London-based partners David Little and Charles Claypool advised on regulatory matters.
Morrison & Foerster was led by M&A partner and Tokyo office head Ken Siegel, San Francisco-based corporate partner and co-head of the firm’s corporate department Eric McCrath and London-based corporate partner Gary Brown.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]